Robert E. Mosser

Array ( [id] => 9552306 [patent_doc_number] => 08759354 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-24 [patent_title] => 'Pharmaceutical composition comprising pyrazine derivative, and method of using pyrazine derivative in combination' [patent_app_type] => utility [patent_app_number] => 12/527260 [patent_app_country] => US [patent_app_date] => 2008-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3660 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12527260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8328752 [patent_doc_number] => 08236848 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-07 [patent_title] => 'Diindolylmethane for the treatment of HPV infection' [patent_app_type] => utility [patent_app_number] => 12/070115 [patent_app_country] => US [patent_app_date] => 2008-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10375 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12070115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4853165 [patent_doc_number] => 20080318908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'USE OF GABA AND GABAB AGONISTS' [patent_app_type] => utility [patent_app_number] => 12/029650 [patent_app_country] => US [patent_app_date] => 2008-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7393 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318908.pdf [firstpage_image] =>[orig_patent_app_number] => 12029650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6196649 [patent_doc_number] => 20110028407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'ENHANCEMENT OF INNATE RESISTANCE TO INFECTION' [patent_app_type] => utility [patent_app_number] => 12/526325 [patent_app_country] => US [patent_app_date] => 2008-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11668 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028407.pdf [firstpage_image] =>[orig_patent_app_number] => 12526325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4899936 [patent_doc_number] => 20080119550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'USE OF HYDROXYBENZOIC ACIDS AND THEIR ESTERS AND ANALOGUES FOR PREVENTING OR TREATING VIRUS INFECTION' [patent_app_type] => utility [patent_app_number] => 12/024833 [patent_app_country] => US [patent_app_date] => 2008-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8683 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20080119550.pdf [firstpage_image] =>[orig_patent_app_number] => 12024833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6445719 [patent_doc_number] => 20100144729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'COUMARIN DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/524943 [patent_app_country] => US [patent_app_date] => 2008-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7496 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144729.pdf [firstpage_image] =>[orig_patent_app_number] => 12524943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4873972 [patent_doc_number] => 20080200706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'Conjugated Linoleic Acid Compositions' [patent_app_type] => utility [patent_app_number] => 12/020820 [patent_app_country] => US [patent_app_date] => 2008-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16639 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20080200706.pdf [firstpage_image] =>[orig_patent_app_number] => 12020820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4846477 [patent_doc_number] => 20080182885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'Modified Azole Compounds As Antifungal and Antibacterial Agents' [patent_app_type] => utility [patent_app_number] => 12/019942 [patent_app_country] => US [patent_app_date] => 2008-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5041 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20080182885.pdf [firstpage_image] =>[orig_patent_app_number] => 12019942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6547805 [patent_doc_number] => 20100016433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'NERVE-REGENERATING AGENT' [patent_app_type] => utility [patent_app_number] => 12/520989 [patent_app_country] => US [patent_app_date] => 2007-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3428 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016433.pdf [firstpage_image] =>[orig_patent_app_number] => 12520989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6257430 [patent_doc_number] => 20100029652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'Combination Therapy For Treating Hepatitis C Infections' [patent_app_type] => utility [patent_app_number] => 12/519470 [patent_app_country] => US [patent_app_date] => 2007-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9884 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029652.pdf [firstpage_image] =>[orig_patent_app_number] => 12519470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6603280 [patent_doc_number] => 20100063005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'Methods for Treating Cystic Fibrosis or Pneumonia with Bacterial Infection via Pulmonary Administration of Fosfomycin' [patent_app_type] => utility [patent_app_number] => 12/518654 [patent_app_country] => US [patent_app_date] => 2007-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3974 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20100063005.pdf [firstpage_image] =>[orig_patent_app_number] => 12518654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4753317 [patent_doc_number] => 20080161393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Use of prodrugs of GABA analogs for treating disease' [patent_app_type] => utility [patent_app_number] => 12/001067 [patent_app_country] => US [patent_app_date] => 2007-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42228 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20080161393.pdf [firstpage_image] =>[orig_patent_app_number] => 12001067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4833934 [patent_doc_number] => 20080132481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'INTERLEUKIN-4 GENE EXPRESSION INHIBITORS' [patent_app_type] => utility [patent_app_number] => 11/947922 [patent_app_country] => US [patent_app_date] => 2007-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 36638 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20080132481.pdf [firstpage_image] =>[orig_patent_app_number] => 11947922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7712261 [patent_doc_number] => 08093220 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-10 [patent_title] => 'Combination of an HDAC inhibitor and an antimetabolite' [patent_app_type] => utility [patent_app_number] => 12/516656 [patent_app_country] => US [patent_app_date] => 2007-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8418 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/093/08093220.pdf [firstpage_image] =>[orig_patent_app_number] => 12516656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7682230 [patent_doc_number] => 20100022578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS' [patent_app_type] => utility [patent_app_number] => 12/441812 [patent_app_country] => US [patent_app_date] => 2007-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21698 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022578.pdf [firstpage_image] =>[orig_patent_app_number] => 12441812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4873758 [patent_doc_number] => 20080200492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'METHODS FOR THE TREATMENT OF ALCOHOL ABUSE, ADDICTION AND DEPENDENCY' [patent_app_type] => utility [patent_app_number] => 11/940397 [patent_app_country] => US [patent_app_date] => 2007-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9853 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20080200492.pdf [firstpage_image] =>[orig_patent_app_number] => 11940397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5972741 [patent_doc_number] => 20110152263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'COMPOSITION AND METHOD FOR INHIBITING NOROVIRUS INFECTION' [patent_app_type] => utility [patent_app_number] => 11/940794 [patent_app_country] => US [patent_app_date] => 2007-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5652 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152263.pdf [firstpage_image] =>[orig_patent_app_number] => 11940794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6444050 [patent_doc_number] => 20100144626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Treatment of Multi-Drug Resistant Bacterial Infections' [patent_app_type] => utility [patent_app_number] => 12/515145 [patent_app_country] => US [patent_app_date] => 2007-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4295 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144626.pdf [firstpage_image] =>[orig_patent_app_number] => 12515145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436344 [patent_doc_number] => 20090170931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'EP2 and EP4 agonists as agents for the treatment of influenza a viral infection' [patent_app_type] => utility [patent_app_number] => 11/985335 [patent_app_country] => US [patent_app_date] => 2007-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7647 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170931.pdf [firstpage_image] =>[orig_patent_app_number] => 11985335 [rel_patent_id] =>[rel_patent_doc_number] =>)